Within these eleven studies, analysis of tumor mutational events varied from driver gene genotyping of KRAS, BRAF, and/or NRAS [39,42,68], to analysis of the genome-wide mutational spectrum of the tumor [43,44,57,72]. The gene discussed is NRAS; the disease is neoplasm.